In the first few years following its introduction to the market, several animal and in vitro experiments and clinical studies demonstrated its capacity to remove various albumin-bound and water-soluble metabolites that accumulate in liver failure and are implicated in some of its major complications, such as HE [3, 10]. The gene discussed is ALB; the disease is liver failure.